Back To: Home : Featured Technology : Assay Development

CLICK HERE FOR WHAT'S NEW IN:
 

Thermo Fisher Scientific, universities to accelerate biomarker identification for cancer
May 2010
SHARING OPTIONS:

SAN JOSE, Calif.Thermo Fisher Scientific Inc.'s Biomarker Research Initiative in Mass Spectrometry (BRIMS) Center has extended its two-year-old collaboration with George Mason University's Center for Applied Proteomics and Molecular Medicine (CAPMM), Johns Hopkins University and Toronto's University Health Network (UHN) on the verification and validation of protein biomarkers for cancer and other diseases. The BRIMS Center has developed targeted SRM-based quantitative mass spectrometry workflows that enable rapid assay development and cross validation of biomarker assays across a network of laboratories. The collaborators used these biomarkers and assays to perform research on identical Thermo Scientific TSQ Quantum Ultra triple quadrupole mass spectrometer platforms. The groups will now continue to apply the SRM-based workflow to previously validated clinical biomarkers.

Back


PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.